XML 59 R43.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Segment and Geographic Information (Tables) | 12 Months Ended
--- | ---
Dec. 28, 2018
Segment Reporting [Abstract] |
Schedule of segment sales by product line | The following table presents sales by product line for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Segment sales by product line: |  |  |  |  |
Medical |  |  |  |  |
Cardio & Vascular | $ | 585,464 |  |  | $ | 530,831 |  |  | $ | 484,891 |
Cardiac & Neuromodulation | 443,347 |  |  | 428,275 |  |  | 439,375 |
Advanced Surgical, Orthopedics & Portable Medical | 133,225 |  |  | 120,006 |  |  | 109,557 |
Total Medical | 1,162,036 |  |  | 1,079,112 |  |  | 1,033,823 |
Non-Medical | 52,976 |  |  | 56,968 |  |  | 41,679 |
Total sales | $ | 1,215,012 |  |  | $ | 1,136,080 |  |  | $ | 1,075,502 |
Schedule of Revenue by Major Customers by Reporting Segments | A significant portion of the Company’s sales for fiscal years 2018, 2017 and 2016 and accounts receivable at December 28, 2018 and December 29, 2017 were to three customers as follows:
| Sales |  | Accounts Receivable
| 2018 |  | 2017 |  | 2016 |  | December 28, 2018 |  | December 29, 2017
Customer A | 21% |  | 22% |  | 24% |  | 11% |  | 11%
Customer B | 19% |  | 20% |  | 21% |  | 18% |  | 21%
Customer C | 12% |  | 11% |  | 12% |  | 20% |  | 20%
| 52% |  | 53% |  | 57% |  | 49% |  | 52%
Schedule of segment depreciation and amortization | The following table presents depreciation and amortization expense for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Segment depreciation and amortization: |  |  |  |  |
Medical | $ | 71,922 |  |  | $ | 72,314 |  |  | $ | 65,528 |
Non-Medical | 1,364 |  |  | 2,675 |  |  | 2,346 |
Total depreciation and amortization included in segment income from operations | 73,286 |  |  | 74,989 |  |  | 67,874 |
Unallocated depreciation and amortization | 8,252 |  |  | 6,194 |  |  | 4,994 |
Total depreciation and amortization | $ | 81,538 |  |  | $ | 81,183 |  |  | $ | 72,868 |
Schedule of segment income (loss) from operations | The following table presents income from operations for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Segment income from operations: |  |  |  |  |
Medical | $ | 224,893 |  |  | $ | 197,212 |  |  | $ | 170,101 |
Non-Medical | 14,697 |  |  | 11,335 |  |  | 1,513 |
Total segment income from operations | 239,590 |  |  | 208,547 |  |  | 171,614 |
Unallocated operating expenses | (84,035 | ) |  | (82,898 | ) |  | (78,691 | )
Operating income | 155,555 |  |  | 125,649 |  |  | 92,923 |
Unallocated expenses, net | (94,439 | ) |  | (76,390 | ) |  | (64,758 | )
Income before benefit for income taxes | $ | 61,116 |  |  | $ | 49,259 |  |  | $ | 28,165 |
Schedule of long-lived tangible assets and identifable assets by geographic area | The following table presents PP&E by geographic area as of December 28, 2018 and December 29, 2017. In these tables, PP&E is aggregated based on the physical location of the tangible long-lived assets (in thousands).
| December 28, 2018 |  | December 29, 2017
Long-lived tangible assets by geographic area: |  |  |
United States | $ | 151,851 |  |  | $ | 157,808 |
Mexico | 34,606 |  |  | 28,985 |
Ireland | 32,190 |  |  | 33,992 |
Rest of world | 12,622 |  |  | 14,395 |
Total | $ | 231,269 |  |  | $ | 235,180 |
The following table presents total assets for the Company’s reportable segments as of December 28, 2018 and December 29, 2017 (in thousands).
| December 28, 2018 |  | December 29, 2017
Identifiable assets: |  |  |
Medical(1) | $ | 2,186,565 |  |  | $ | 2,687,227 |
Non-Medical | 53,812 |  |  | 54,071 |
Total reportable segments | 2,240,377 |  |  | 2,741,298 |
Unallocated assets | 86,304 |  |  | 107,047 |
Total assets | $ | 2,326,681 |  |  | $ | 2,848,345 |
Schedule of expenditures for tangible long-lived assets, excluding acquisitions | The following table presents capital expenditures for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Expenditures for tangible long-lived assets: |  |  |  |  |
Medical | $ | 34,615 |  |  | $ | 20,896 |  |  | $ | 27,014 |
Non-Medical | 573 |  |  | 661 |  |  | 1,451 |
Total reportable segments | 35,188 |  |  | 21,557 |  |  | 28,465 |
Unallocated long-lived tangible assets | 6,110 |  |  | 8,783 |  |  | 8,251 |
Total expenditures | $ | 41,298 |  |  | $ | 30,340 |  |  | $ | 36,716 |
Schedule of sales by geographic area | The following table presents sales by significant country for fiscal years 2018, 2017 and 2016. In these tables, sales are allocated based on where the products are shipped (in thousands).
| 2018 |  | 2017 |  | 2016
Sales by geographic area: |  |  |  |  |
United States | $ | 687,259 |  |  | $ | 662,133 |  |  | $ | 625,670 |
Non-Domestic locations: |  |  |  |  |
Puerto Rico | 146,500 |  |  | 140,184 |  |  | 162,343 |
Costa Rica | 62,044 |  |  | 55,364 |  |  | 53,501 |
Rest of world | 319,209 |  |  | 278,399 |  |  | 233,988 |
Total sales | $ | 1,215,012 |  |  | $ | 1,136,080 |  |  | $ | 1,075,502 |
Segment Reporting Disclosure [Text Block] | The following table presents sales by customer for fiscal year 2018.
Customer |  | Medical |  | Non-Medical
Customer A |  | 22 | % |  | — | %
Customer B |  | 19 | % |  | — | %
Customer C |  | 12 | % |  | — | %
Customer D |  | — | % |  | 28 | %
All other customers |  | 47 | % |  | 72 | %
(17.) SEGMENT AND GEOGRAPHIC INFORMATION The Company organizes its business into two reportable segments: (1) Medical and (2) Non-Medical. This segment structure reflects the financial information and reports used by the Company’s management, specifically its Chief Operating Decision Maker (“CODM”), to make decisions regarding the Company’s business, including resource allocations and performance assessments. This segment structure reflects the Company’s current operating focus in compliance with ASC 280, Segment Reporting. The Company defines segment income from operations as sales less cost of sales including amortization and expenses attributable to segment-specific selling, general, administrative, research, development, engineering and other operating activities. The remaining unallocated operating and other expenses are primarily administrative corporate headquarter expenses and capital costs that are not allocated to reportable segments. Transactions between the two segments are not significant. (17.) SEGMENT AND GEOGRAPHIC INFORMATION (Continued) The following table presents sales by product line for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Segment sales by product line: |  |  |  |  |
Medical |  |  |  |  |
Cardio & Vascular | $ | 585,464 |  |  | $ | 530,831 |  |  | $ | 484,891 |
Cardiac & Neuromodulation | 443,347 |  |  | 428,275 |  |  | 439,375 |
Advanced Surgical, Orthopedics & Portable Medical | 133,225 |  |  | 120,006 |  |  | 109,557 |
Total Medical | 1,162,036 |  |  | 1,079,112 |  |  | 1,033,823 |
Non-Medical | 52,976 |  |  | 56,968 |  |  | 41,679 |
Total sales | $ | 1,215,012 |  |  | $ | 1,136,080 |  |  | $ | 1,075,502 |
A significant portion of the Company’s sales for fiscal years 2018, 2017 and 2016 and accounts receivable at December 28, 2018 and December 29, 2017 were to three customers as follows:
| Sales |  | Accounts Receivable
| 2018 |  | 2017 |  | 2016 |  | December 28, 2018 |  | December 29, 2017
Customer A | 21% |  | 22% |  | 24% |  | 11% |  | 11%
Customer B | 19% |  | 20% |  | 21% |  | 18% |  | 21%
Customer C | 12% |  | 11% |  | 12% |  | 20% |  | 20%
| 52% |  | 53% |  | 57% |  | 49% |  | 52%
The following table presents income from operations for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Segment income from operations: |  |  |  |  |
Medical | $ | 224,893 |  |  | $ | 197,212 |  |  | $ | 170,101 |
Non-Medical | 14,697 |  |  | 11,335 |  |  | 1,513 |
Total segment income from operations | 239,590 |  |  | 208,547 |  |  | 171,614 |
Unallocated operating expenses | (84,035 | ) |  | (82,898 | ) |  | (78,691 | )
Operating income | 155,555 |  |  | 125,649 |  |  | 92,923 |
Unallocated expenses, net | (94,439 | ) |  | (76,390 | ) |  | (64,758 | )
Income before benefit for income taxes | $ | 61,116 |  |  | $ | 49,259 |  |  | $ | 28,165 |
The following table presents depreciation and amortization expense for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Segment depreciation and amortization: |  |  |  |  |
Medical | $ | 71,922 |  |  | $ | 72,314 |  |  | $ | 65,528 |
Non-Medical | 1,364 |  |  | 2,675 |  |  | 2,346 |
Total depreciation and amortization included in segment income from operations | 73,286 |  |  | 74,989 |  |  | 67,874 |
Unallocated depreciation and amortization | 8,252 |  |  | 6,194 |  |  | 4,994 |
Total depreciation and amortization | $ | 81,538 |  |  | $ | 81,183 |  |  | $ | 72,868 |
(17.) SEGMENT AND GEOGRAPHIC INFORMATION (Continued) The following table presents total assets for the Company’s reportable segments as of December 28, 2018 and December 29, 2017 (in thousands).
| December 28, 2018 |  | December 29, 2017
Identifiable assets: |  |  |
Medical(1) | $ | 2,186,565 |  |  | $ | 2,687,227 |
Non-Medical | 53,812 |  |  | 54,071 |
Total reportable segments | 2,240,377 |  |  | 2,741,298 |
Unallocated assets | 86,304 |  |  | 107,047 |
Total assets | $ | 2,326,681 |  |  | $ | 2,848,345 |
__________
(1) | Medical segment identifiable assets at December 29, 2017 includes $451.4 million of assets held sale.
The following table presents capital expenditures for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Expenditures for tangible long-lived assets: |  |  |  |  |
Medical | $ | 34,615 |  |  | $ | 20,896 |  |  | $ | 27,014 |
Non-Medical | 573 |  |  | 661 |  |  | 1,451 |
Total reportable segments | 35,188 |  |  | 21,557 |  |  | 28,465 |
Unallocated long-lived tangible assets | 6,110 |  |  | 8,783 |  |  | 8,251 |
Total expenditures | $ | 41,298 |  |  | $ | 30,340 |  |  | $ | 36,716 |
Geographic Area Information The following table presents sales by significant country for fiscal years 2018, 2017 and 2016. In these tables, sales are allocated based on where the products are shipped (in thousands).
| 2018 |  | 2017 |  | 2016
Sales by geographic area: |  |  |  |  |
United States | $ | 687,259 |  |  | $ | 662,133 |  |  | $ | 625,670 |
Non-Domestic locations: |  |  |  |  |
Puerto Rico | 146,500 |  |  | 140,184 |  |  | 162,343 |
Costa Rica | 62,044 |  |  | 55,364 |  |  | 53,501 |
Rest of world | 319,209 |  |  | 278,399 |  |  | 233,988 |
Total sales | $ | 1,215,012 |  |  | $ | 1,136,080 |  |  | $ | 1,075,502 |
The following table presents PP&E by geographic area as of December 28, 2018 and December 29, 2017. In these tables, PP&E is aggregated based on the physical location of the tangible long-lived assets (in thousands).
| December 28, 2018 |  | December 29, 2017
Long-lived tangible assets by geographic area: |  |  |
United States | $ | 151,851 |  |  | $ | 157,808 |
Mexico | 34,606 |  |  | 28,985 |
Ireland | 32,190 |  |  | 33,992 |
Rest of world | 12,622 |  |  | 14,395 |
Total | $ | 231,269 |  |  | $ | 235,180 |
(17.) SEGMENT AND GEOGRAPHIC INFORMATION (Continued) Disaggregation of Revenue by Segment In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations. Additionally, the tables below disaggregate the Company’s revenues based upon significant customers, which are defined as any customer who individually represents 10% or more of a segment’s total revenues, and ship to country, which is defined as any country where 10% or more of a segment’s total revenues are shipped to. The Company believes that these categories best depict how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. The following table presents sales by customer for fiscal year 2018.
Customer |  | Medical |  | Non-Medical
Customer A |  | 22 | % |  | — | %
Customer B |  | 19 | % |  | — | %
Customer C |  | 12 | % |  | — | %
Customer D |  | — | % |  | 28 | %
All other customers |  | 47 | % |  | 72 | %
The following table presents revenues by ship to country for fiscal year 2018.
Ship to Location |  | Medical |  | Non-Medical
United States |  | 56% |  | 66%
Puerto Rico |  | 13% |  | —%
Canada |  | —% |  | 11%
All other Countries |  | 31% |  | 23%

X
- Definition -- None. No documentation exists for this element. -- + References No definition available. + Details
Name: | gb_ReconciliationOfDepreciationAndAmortizationByReportableSegmentToConsolidatedTableTextBlock
Namespace Prefix: | gb_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition -- None. No documentation exists for this element. -- + References No definition available. + Details
Name: | gb_ScheduleOfExpendituresForTangibleLonglivedAssetsBySegmentTableTextBlock
Namespace Prefix: | gb_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer. + References No definition available. + Details
Name: | us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599 + Details
Name: | us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration